Ron Cohen

2020

In 2020, Ron Cohen earned a total compensation of $1.5M as President and Chief Executive Officer at Acorda Therapeutics, a 26% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$700,194
Salary$795,675
Other$8,550
Total$1,504,419

Cohen received $795.7K in salary, accounting for 53% of the total pay in 2020.

Cohen also received $700.2K in non-equity incentive plan and $8.6K in other compensation.

Rankings

In 2020, Ron Cohen's compensation ranked 6,806th out of 13,090 executives tracked by ExecPay. In other words, Cohen earned more than 48.0% of executives.

ClassificationRankingPercentile
All
6,806
out of 13,090
48th
Division
Manufacturing
2,836
out of 5,621
50th
Major group
Chemicals And Allied Products
1,146
out of 2,254
49th
Industry group
Drugs
987
out of 1,954
50th
Industry
Biological Products, Except Diagnostic Substances
236
out of 411
43rd

Pay ratio

Ron Cohen's Pay$1,504,419
Median Employee's Pay$189,329
Pay Ratio

8

to 1

In 2020, the annual total compensation of Ron Cohen was $1,504,419.

The annual total compensation of the median employee at Acorda Therapeutics was $189,329.

The ratio of Ron Cohen's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 23, 2021.

Cohen's colleagues

We found four more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2020.

2020

Burkhard Blank

Acorda Therapeutics

Chief Medical Officer

2020

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2020

David Lawrence

Acorda Therapeutics

Former Chief, Business Operations and Principal Accounting Officer

2020

Kerry Clem

Acorda Therapeutics

Chief Commercial Officer

News

You may also like